Advanced search
Publication Cover
Personalized Medicine Volume 13, 2016 - Issue 6
Submit an article Journal homepage
66
Views
0
CrossRef citations to date
0
Altmetric
Case Series

Case with Triple-Negative Breast Cancer Shows Overexpression of Both Cfos and Tgf-β1 in Node-Positive Tissue

Vesna Ivanović1 Department for Radiobiology & Molecular Genetics, Institute of Nuclear Sciences ‘Vinča’, University of Belgrade, Belgrade, SerbiaCorrespondence[email protected]
View further author information
,
Nasta Dedović-Tanić1 Department for Radiobiology & Molecular Genetics, Institute of Nuclear Sciences ‘Vinča’, University of Belgrade, Belgrade, SerbiaView further author information
,
Zorka Milovanović2 Institute of Oncology & Radiology of Serbia, Belgrade, SerbiaView further author information
,
Silvana Lukić2 Institute of Oncology & Radiology of Serbia, Belgrade, SerbiaView further author information
,
Srdjan Nikolić2 Institute of Oncology & Radiology of Serbia, Belgrade, SerbiaView further author information
,
Vladimir Baltić3 Oncology Institute of Vojvodina, Sremska Kamenica, SerbiaView further author information
,
Bratislav Stojiljković3 Oncology Institute of Vojvodina, Sremska Kamenica, SerbiaView further author information
,
Miroslav Demajo1 Department for Radiobiology & Molecular Genetics, Institute of Nuclear Sciences ‘Vinča’, University of Belgrade, Belgrade, SerbiaView further author information
,
Vesna Mandušić1 Department for Radiobiology & Molecular Genetics, Institute of Nuclear Sciences ‘Vinča’, University of Belgrade, Belgrade, SerbiaView further author information
&
Bogomir Dimitrijević1 Department for Radiobiology & Molecular Genetics, Institute of Nuclear Sciences ‘Vinča’, University of Belgrade, Belgrade, SerbiaView further author information
 show all
Pages 523-530 | Received 25 Mar 2016, Accepted 22 Aug 2016, Published online: 18 Oct 2016

References

  • WHO, International Agency for Research on Cancer, EUCUN, Estimated mortality of breast cancer ( 2012 ). http://eu-cancer.iarc.fr/eucan/CancerOne.aspx?Cancer=46&Gender=2 .
  • Van Poznak C , SomerfieldMR , BastRCet al. Use of biomarkers to guide decisions on systemic therapy for women with metastatic breast cancer: American Society of Clinical Oncology Clinical Practice Guideline . J. Clin. Oncol.33 ( 24 ), 1 – 10 ( 2015 ).
  • De Boer M , Van DijckJA , BultP , BormGF , Tjan-HeijnenVC . Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases . J. Natl Cancer. Inst.102 ( 6 ), 410 – 425 ( 2010 ).
  • Tawfik K , KimlerBF , DavisMK , FanF , TawfikO . Ki-67 expression in axillary lymph node metastases in breast cancer is prognostically significant . Hum. Pathol.44 ( 1 ), 39 – 46 ( 2013 ).
  • Ivanović V , Dedović-TanićN , MilovanovićZet al. Quantification of transforming growth factor beta 1 levels in metastatic axillary lymph node tissue extracts from breast cancer patients: a new specimen source . Anal. Quant. Cytol. Histol.31 ( 5 ), 288 – 295 ( 2009 ).
  • Jamdade VS , SethiN , MundheNA , KumarP , LahkarM , SinhaN . Therapeutic targets of triple-negative breast cancer: a review . Br. J. Pharmacol.172 ( 17 ), 4228 – 4237 ( 2015 ).
  • Bahnassy A , MohanadM , IsmailMF , ShaarawyS , El-BastawisyA , ZekriARN . Molecular biomarkers for prediction of response to treatment and survival in triple-negative breast cancer patients from Egypt . Exp. Mol. Pathol.99 ( 2 ), 303 – 311 ( 2015 ).
  • Morrison CD , ParvaniJG , SchiemannWP . The relevance of the TGF-β paradox to EMT-MET programs . Cancer Lett.341 ( 1 ), 30 – 40 ( 2013 ).
  • Sheen YY , KimMJ , ParkSA , ParkSY , NamJS . Targeting the transforming growth factor-β signaling in cancer therapy . Biomol. Ther.21 ( 5 ), 323 – 331 ( 2013 ).
  • Conolly EC , FreimuthJ , AkhurstRJ . Complexities of TGF-β targeted cancer therapy . Int. J. Biol. Sci.8 ( 7 ), 964 – 978 ( 2012 ).
  • Kontos CK , ScorilasA , PapavassiliouAG . The role of transcription factors in laboratory medicine . Clin. Chem. Lab. Med.51 ( 8 ), 1563 – 1571 ( 2013 ).
  • Kim SJ , AngelP , LafyatisRet al. Autoinduction of transforming growth factor β1 is mediated by the AP-1 complex . Mol. Cell. Biol.10 ( 4 ), 1492 – 1497 ( 1990 ).
  • Prusty BK , DasBC . Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin . Int. J. Cancer113 ( 6 ), 951 – 960 ( 2005 ).
  • Liu G , DingW , LiuX , MulderKM . c-Fos is required for TGF-β1 production and the associated paracrine migratory effects of human colon carcinoma cells . Mol. Carcinog.45 ( 8 ), 582 – 593 ( 2006 ).
  • Bhola NE , BalkoJM , DuggerTCet al. TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer . J. Clin. Invest.123 ( 3 ), 1348 – 1358 ( 2013 ).
  • Islam F , GopalanV , SmithRA , LamAKY . Translational potential of cancer stem cells: a review of the detection of cancer stem cells and their roles in cancer recurrence and cancer treatment . Exp. Cell Res.335 ( 1 ), 135 – 147 ( 2015 ).
  • Dittmer J , RodyA . Cancer stem cells in breast cancer . Histol. Histopathol.28 ( 7 ), 827 – 838 ( 2013 ).
  • Michaelson JS , SilversteinM , SgroiDet al. The effect of tumor size and lymph node status on breast carcinoma lethality . Cancer98 ( 10 ), 2133 – 2143 ( 2003 ).
  • Leake R , BarnesD , PinderSet al. Immunohistochemical detection of steroid receptors in breast cancer: a working protocol . J. Clin. Pathol.53 ( 8 ), 634 – 635 ( 2000 ).
  • Greene FI , PageDL , FlemingIDet al. Breast . In : AJCC Cancer Staging Manual (6th Edition) . Springer , NY, USA , 221 – 240 ( 2002 ).
  • Milde-Langosch K . The Fos family of transcription factors and their role in tumourigenesis . Eur. J. Cancer41 ( 16 ), 2449 – 2461 ( 2005 ).
  • Zu X , ZhangQ , CaoRet al. Transforming growth factor-β signaling in tumor initiation, progression and therapy in breast cancer: an update . Cell Tissue Res.347 , 73 – 84 ( 2012 ).
  • Von Minckwitz G , MartinM . Neoadjuvant treatments for triple-negative breast cancer (TNBC) . Ann. Oncol.23 ( Suppl. 6 ), vi35 – vi39 ( 2012 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.